Ultomiris 1,100 MG/11 ML vial 11ML
Ended Awarded
- Contract number
- SPE2DB25FKE65
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,351
Award facts
- Contract value 100% obligated
- $57,350.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $57,350.96 to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegloticase) 1,100 mg/11 ml vials under a firm fixed price contract. The award was made on September 29, 2025, with an ultimate completion date of October 21, 2025, and performance will take place at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, leverages its comprehensive pharmaceutical supply agreement with DLA to fulfill critical medication requirements for military and veteran healthcare systems. The Ultomiris delivery under this order supports the Defense Health Agency and other government healthcare systems requiring specialty medications. As the prime contractor holding no set-aside designation on this award, AmerisourceBergen continues its extensive portfolio of federal pharmaceutical deliveries, which encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FKE65?
SPE2DB25FKE65 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FKE65 worth?
The government has obligated $57,351 on SPE2DB25FKE65.
Is contract SPE2DB25FKE65 an order under another contract?
Yes. SPE2DB25FKE65 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKE65 competed?
The extent of competition for SPE2DB25FKE65 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award